Particle therapy in the future of precision therapy

48Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The first hospital-based treatment facilities for particle therapy started operation about thirty years ago. Since then, the clinical experience with protons and carbon ions has grown continuously and more than 200,000 patients have been treated to date. The promising clinical results led to a rapidly increasing number of treatment facilities and many new facilities are planned or under construction all over the world. An inverted depth-dose profile combined with potential radiobiological advantages make charged particles a precious tool for the treatment of tumours that are particularly radioresistant or located nearby sensitive structures. A rising number of trials have already confirmed the benefits of particle therapy in selected clinical situations and further improvements in beam delivery, image guidance and treatment planning are expected. This review summarises some physical and biological characteristics of accelerated charged particles and gives some examples of their clinical application. Furthermore, challenges and future perspectives of particle therapy will be discussed.

Cite

CITATION STYLE

APA

Schaub, L., Harrabi, S. B., & Debus, J. (2020, October 1). Particle therapy in the future of precision therapy. British Journal of Radiology. British Institute of Radiology. https://doi.org/10.1259/bjr.20200183

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free